|
Comparison of our TSH reference intervals to previously published reference intervals (2.5, 50 and 97.5%) of different age groups. |
|||||||
| Soldin et al., 1995 Abbott IMx® |
Zurakowski et al., 1999 DELFIA® |
Elmlinger et al., 2001 Immulite® |
Djemli et al., 2004 Access 2® |
Hübner et al., 2002 Advia Centaur® |
Kapelari et al., Advia Centaur® |
||
|
|
|||||||
| Age |
|||||||
|
|
|||||||
| TSH |
[mU/L] |
[mU/L] |
[mU/L] |
[mU/L] |
[mU/L] |
[mU/L] |
|
|
|
|||||||
| n = 533 |
n = 5,558 |
n = 762 |
n = 706 |
n = 460 |
n = 1,209 |
||
|
|
|||||||
| 1 d – 7 d |
F: 0.72 – 13.1 |
n.d. |
1.79 – 4.63 – 9.69 |
F: 1.5 – 3.3 – 6.5 |
0.13 – 9.23 a |
0.75 – 3.50 – 16.89 |
|
|
|
|||||||
| 8 d–15 d |
M: 0.52 – 16.0 |
n.d. |
1.80 – 3.71 – 7.97 |
M: 0.7 – 2.4 – 9.8 |
0.16 – 8.48 b |
||
|
|
|||||||
| 15 d – 1 m |
n.d. |
n.d. |
|||||
|
|
|||||||
| 1 – 12 m |
0.8 – 2.2 – 6.3 |
F: 1.0 – 2.4 – 5.7 |
0.3 – 1.73 – 5.88 c |
1.30 – 2.85 – 7.09 |
|||
|
|
|||||||
| 1 – 2 y |
0.63 – 2.04 – 4.12 |
M: 0.7 – 2.1 – 5.9 |
|||||
|
|
|||||||
| 2 – 3 y |
F: 0.46 – 8.1 |
F: 0.7 – 2.0 – 5.9 |
n.d. |
0.42 – 1.98 – 4.79 |
1.00 – 2.70 – 5.42 |
||
|
|
|||||||
| 3 – 4 y |
M: 0.55 – 7.1 |
M: 0.7 – 2.1 – 6.0 |
n.d. |
||||
|
|
|||||||
| 4 – 5 y |
0.53 – 1.60 – 2.94 |
n.d. |
|||||
|
|
|||||||
| 5 – 6 y |
F: 0.36 – 5.8 |
n.d. |
|||||
|
|
|||||||
| 7 – 8 |
M: 0.37 – 6.0 |
F: 0.6 – 1.8 – 5.1 |
0.80 – 1.86 – 3.48 |
n.d. |
0.48 – 1.87 – 4.67 |
0.90 – 2.30 – 4.40 |
|
|
|
|||||||
| 9 – 10 |
M: 0.7 – 1.9 – 5.4 |
0.85 – 2.00 – 3.50 |
F: 0.9 – 2.0 – 4.0 |
||||
|
|
|||||||
| M: 1.0 – 1.9 – 3.7 |
|||||||
|
|
|||||||
| 11 |
0.85 – 1.90 – 3.33 |
||||||
|
|
|||||||
| 12 |
F: 0.5 – 1.5 – 4.4 |
0.86 – 1.90 – 3.21 |
F: 0.7 – 1.7 – 3.4 |
0.53 – 1.78 – 4.58 |
0.90 – 2.10 – 4.10 |
||
|
|
|||||||
| 13 |
M: 0.6 – 1.7 – 4.9 |
0.80 – 1.81 – 3.08 |
M: 0.8 – 1.8 – 3.9 |
||||
|
|
|||||||
| 14 |
0.76 – 1.70 – 2.83 |
||||||
|
|
|||||||
| 15 |
0.70 – 1.56 – 2.55 |
||||||
|
|
|||||||
| 16 |
0.64 – 1.54 – 2.51 |
F: 0.6 – 1.5 – 3.7 |
0.56 – 2.00 – 4.53 |
0.70 – 1.70 – 3.93 |
|||
|
|
|||||||
| 17 |
F: 0.5 – 1.3 – 3.9 |
0.62 – 1.51 – 2.42 |
M: 0.7 – 1.4 – 2.8 |
||||
|
|
|||||||
| 18 – 19 |
M: 0.5 – 1.6 – 4.4 |
0.52 – 1.36 – 2.36 |
n.d. |
||||
|
a 1 d – 3 d b 4 d – 30 d c 61 d – 12 m | |||||||
Kapelari et al. BMC Endocrine Disorders 2008 8:15 doi:10.1186/1472-6823-8-15 |
|||||||